Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas
about
sameAs
Ligand-induced tyrosine phosphorylation of cysteinyl leukotriene receptor 1 triggers internalization and signaling in intestinal epithelial cellsSeminal Fluid-Mediated Inflammation in Physiology and Pathology of the Female Reproductive TractLipidome in colorectal cancerEicosanoid pathway in colorectal cancer: Recent updatesCysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in malesTargeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cellsBLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation5-lipoxygenase mRNA and protein isoformsCysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancerCysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancerROS-mediated autophagy induced by dysregulation of lipid metabolism plays a protective role in colorectal cancer cells treated with gambogic acid.Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer.Expression of 5-lipoxygenase in human colorectal cancerEicosanoids and cancerOverexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis.Regulation of cysteinyl leukotriene receptor 2 expression--a potential anti-tumor mechanism.Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival.The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cellsThe eicosanoid cascade: possible role in gliomas and meningiomas.Menstrual pain and epithelial ovarian cancer riskLeukotriene receptor expression in esophageal squamous cell cancer and non-transformed esophageal epithelium: a matched case control study.Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer PreventionWhat are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal TumorigenesisUpregulation of leukotriene receptors in gastric cancer.Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells.Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer.Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.Inflammatory pathways in the early steps of colorectal cancer development.Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.The impact of inflammatory lipid mediators on colon cancer-initiating cells.5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation.Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway.Nuclear expression of glycogen synthase kinase-3β and lack of membranous β-catenin is correlated with poor survival in colon cancer.Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients.An inhibitor of arachidonate 5-lipoxygenase, Nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells.Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells.The inflammatory mediator leukotriene D4 induces beta-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells.
P2860
Q24322961-81D2A3C5-DD7A-4EDF-9796-8D52BF6BB8D6Q26742070-050AF615-DAC7-46B6-B4B0-E56002B18B7FQ26766296-197625A3-91AC-4479-BAB6-77CB63CE3AC4Q26778011-C158B22F-9741-40CC-A2AB-AC78684E32D4Q28196697-DB86156C-1268-4960-9D05-D0EF668EE0A4Q28213181-77478D2D-F56A-417E-922F-963DFB366278Q28293407-5F616B29-46BB-4E5F-A814-D96DD823DB2DQ28298153-2BC61E76-13FD-4808-8828-BF5D741296ABQ28308101-CDEC6032-FD12-4618-B9AE-48D3AD8BC50AQ28536784-CCC8338C-AFD4-402A-A9A1-AF6C1349F14EQ33583930-C06B6ED1-67A8-4C26-B801-053393484528Q33798596-A3F6AD61-F7DC-4FEC-B48A-0E7B38AE3969Q33869146-F71A6DC9-2066-4273-9CD4-5140045FD246Q33966203-E3A58A04-3684-42C0-8CD8-62EC73F69F4EQ34030871-5CDB2987-3133-4188-96CA-2A61867FF0F4Q34110714-67651A63-8F00-49CF-9780-051927886F28Q34173738-061E55C0-A8A1-4727-97A6-9571AD7A862EQ34799962-67340082-94C4-4903-8284-905F4334C84EQ35615457-404632EA-BFA4-4A56-8C04-628B13E724EEQ35845474-42FE35B8-9F18-41E5-8EBF-1DED44C6DD77Q36091008-724F23A3-46BF-4623-9E08-38CBB482EE27Q36503568-88D863D1-83A8-49C7-A62E-72B750743DB6Q36572139-15ED07E4-1594-4F18-8482-8E9D5D451EE0Q37078077-4D7E3FEF-4449-471A-90E2-E56BA8E5CE32Q37137400-73B3FD0A-D95C-4D2C-9EA7-B92793B9491DQ37492447-055B6F09-A443-4AC2-A725-16C6D14E9C9FQ37947960-556837B9-150C-4B55-A644-48335AF0C54DQ37963769-515A0236-E1F5-470F-A88D-B81F61FC6D89Q38238739-FE59B961-304E-45D5-B7D4-87FBA332DA87Q38660494-D385077D-9633-498E-BB39-ADA7A25B8ECDQ38723771-745DD41F-2940-4AA8-8E07-9EEA38D32927Q38963031-6F27F935-BFB3-4FF9-B6C1-B6BF064C8206Q39042181-EF5D33B3-8235-43BF-A32C-358CDEC2CFC1Q39104480-AF5C08E3-F53D-491F-A49E-A14EA1938E73Q39198249-67649970-BE71-4FB6-93C4-9BF9B73B487EQ39658216-9D0E6108-FB75-46C2-A5F8-CD7D899D8859Q39661086-7F123505-05CC-4234-BA28-385122FB2D08Q40005941-24F5FA3E-B8AF-47D3-A268-2A391DB9853EQ40277131-24CCF9A7-CDDA-4FF8-B15B-1A3D5DE582E2Q40331160-09305A09-3F69-4F47-AB0F-73EDA3E91094
P2860
Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Expression of the leukotriene ...... in colorectal adenocarcinomas
@ast
Expression of the leukotriene ...... in colorectal adenocarcinomas
@en
Expression of the leukotriene ...... in colorectal adenocarcinomas
@nl
type
label
Expression of the leukotriene ...... in colorectal adenocarcinomas
@ast
Expression of the leukotriene ...... in colorectal adenocarcinomas
@en
Expression of the leukotriene ...... in colorectal adenocarcinomas
@nl
prefLabel
Expression of the leukotriene ...... in colorectal adenocarcinomas
@ast
Expression of the leukotriene ...... in colorectal adenocarcinomas
@en
Expression of the leukotriene ...... in colorectal adenocarcinomas
@nl
P2093
P3181
P356
P1433
P1476
Expression of the leukotriene ...... in colorectal adenocarcinomas
@en
P2093
Anita Sjölander
Christian Kamp Nielsen
Göran Landberg
Helge Löfberg
Joan Campbell
John F Ohd
P3181
P356
10.1053/GAST.2003.50011
P407
P577
2003-01-01T00:00:00Z